Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/20843
Title: Insights on the properties of levofloxacin-adsorbed Sr- and Mg-doped calcium phosphate powders
Author: Marques, Catarina F.
Matos, Ana C.
Ribeiro, Isabel A. C.
Goncalves, Lidia M.
Bettencourt, Ana
Ferreira, Jose M. F.
Keywords: BETA-TRICALCIUM PHOSPHATE
DELIVERY-SYSTEM
IN-VITRO
DRUG-DELIVERY
BONE-CEMENT
EXPERIMENTAL OSTEOMYELITIS
DEFICIENT APATITE
RELEASE KINETICS
HYDROXYAPATITE
INFECTION
Issue Date: 2016
Publisher: SPRINGER
Abstract: Several types of biodegradable materials have been investigated for the treatment of osteomyelitis. Calcium phosphate (CaP) ceramics are among the most performing materials due to their resemblance to human hard tissues in terms of mineralogical composition, and proven ability to adsorb and deliver a number of drugs. This research work was intended to study the suitability of modified CaP powders loaded with a fluoroquinolone as drug delivery systems for osteomyelitis treatment. Levofloxacin (LEV) was chosen due to the well-recognized antistaphylococcal activity and adequate penetration into osteoarticular tissues. Substituted CaP powders (5 mol% Sr2+ or 5 mol% Mg2+) were synthesised through aqueous precipitation. The obtained powders were characterised by X-ray diffraction, SEM and FTIR analysis. The X-ray diffraction patterns confirmed the presence of HA and beta-tricalcium phosphates (beta-TCP) phases in doped compositions, especially in the case of Mg-doped system. The fixation of LEV at the surface of the particles occurred only by physisorption. Both the in vitro microbiological susceptibility, against Staphylococcus spp, and biocompatibility of LEV-loaded CaP powders have not been compromised.
Peer review: yes
URI: http://hdl.handle.net/10773/20843
DOI: 10.1007/s10856-016-5733-2
ISSN: 0957-4530
Publisher Version: 10.1007/s10856-016-5733-2
Appears in Collections:CICECO - Artigos



FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.